Study finds effectiveness of topical corticosteroid regimen for eosinophilic esophagitis Jacinthlyn Sylvia16 Dec 2024 8:30 PM ISTA new study published in the Clinical Gastroenterology and Hepatology journal examined the effectiveness of topical corticosteroid (tCS) regimens...
Sanofi, Regeneron Dupixent approved in EU for young children with eosinophilic esophagitis Ruchika Sharma7 Nov 2024 3:55 PM ISTParis: Sanofi has announced that the European Medicines Agency has approved Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) in...
Dupixent recommended for EU approval by CHMP to treat eosinophilic esophagitis in children as young as 1 year old: Sanofi Ruchika Sharma22 Sept 2024 1:30 PM ISTParis: Sanofi has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive...
Twice-daily PPI dosage improves outcomes among patients of eosinophilic esophagitis: Study Jacinthlyn Sylvia30 March 2024 12:45 AM ISTA recent study by Mayssan Muftah and colleagues explored the most effective dosing strategies for treating Eosinophilic Esophagitis (EoE) which is a...
FDA approves budesonide oral suspension for treatment of eosinophilic esophagitis Dr. Kamal Kant Kohli14 Feb 2024 10:00 AM ISTThe Food and Drug Administration (FDA) has approved EOHILIA (budesonide) oral suspension for treatment of eosinophilic esophagitis among adults and...
Takeda Eohilia gets USFDA nod for people aged 11 years and older with eosinophilic esophagitis Ruchika Sharma13 Feb 2024 1:30 PM ISTOsaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved EOHILIA (budesonide oral suspension), the first and...
Higher-exposure to dupilumab may effect weight gain among children with eosinophilic esophagitis Niveditha Subramani2 Feb 2024 1:45 AM ISTDupilumab is a popular drug commonly marketed as Dupixent. It was first approved by the FDA in 2017 and is currently used to treat atopic dermatitis,...
Sanofi Dupixent approved by USFDA for pediatric patients aged 1 to 11 years with eosinophilic esophagitis Ruchika Sharma28 Jan 2024 2:30 PM ISTParis: Sanofi has announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for the treatment of...
Sanofi Dupixent sBLA for treatment of eosinophilic esophagitis in children aged 1 to 11 accepted for USFDA priority review Ruchika Sharma28 Sept 2023 2:30 PM ISTParis: Sanofi has announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License...
Obese children have increased risk of eosinophilic esophagitis Jacinthlyn Sylvia29 Jun 2023 8:00 PM ISTWhen diagnosed with eosinophilic esophagitis (EoE), about one-third of children had obesity or overweight status, finds an article published in Annals...
Elimination diets show similar histologic and endoscopic outcome in eosinophilic esophagitis patients Jacinthlyn Sylvia27 March 2023 9:30 AM ISTHistologic remission rates and improvement in histologic and endoscopic features were similar in adults with eosinophilic esophagitis after one-food...
Allergen immunotherapy may help achieve remission in eosinophilic esophagitis Jacinthlyn Sylvia7 March 2023 8:00 PM ISTA recent review by Joshua Ang presented in the Scientific Abstract Session of American Academy of Allergy, Asthma & Immunology Annual Meeting...
